Top Markets
Coin of the day
Holy Stone Healthcare Co., Ltd. Holy Stone Healthcare Co., Ltd.

Holy Stone Healthcare Co., Ltd.

4194
Pozycja w akcjach #27776
Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and... Holy Stone Healthcare Co., Ltd., together with its subsidiaries, develops and sells hyaluronic acid-related therapeutic products in Taiwan. The company offers RenehaVis and SportVis, which are injectable medical devices for osteoarthritis and soft tissue injuries; TRUD, a medical device that contains a mixture of hyaluronic acid used for the treatment and prevention of ulcerative colitis in inflammatory bowel disease (IBD); and GAF, a gel for anal fissure healing. It also develops IBD98-M, an oral capsule that is in a Phase IIa trial for ulcerative colitis; CA102N, a receptor-targeted chemotherapy that is in a Phase II trial for metastatic colorectal cancer, as well as in a pre-clinical stage for pancreatic ductal adenocarcinoma and a discovery stage for triple-negative breast cancer; ND108E, a CNS-targeted HA conjugate that is in a pre-clinical trial for Alzheimer’s disease; AMD112, a non-invasive HA-conjugated small molecule therapy that is in a pre-clinical trial for wet age-related macular degeneration and other neovascular retinal diseases; and HylCaryo, a hyaluronic acid (HA)-derived nanoparticle platform in a discovery stage. In addition, the company engages in general investment; development and sale of medical devices; biotechnology services; and patent application for pharmaceutical products. Holy Stone Healthcare Co., Ltd. was founded in 2001 and is headquartered in Taipei, Taiwan.
Cena akcji
$0.20478574
Kapitalizacja rynkowa
$29.89M
Zmiana (1 dzień)
2.38%
Zmiana (1 rok)
-43.60%
Kraj
TW
Handel Holy Stone Healthcare Co., Ltd. (4194)

Kategoria

Historia ceny akcji dla Holy Stone Healthcare Co., Ltd. (4194)
Najwyższa cena zamknięcia: $0.20 dnia 2026-08-01

Najniższa cena zamknięcia: $3.08 dnia 2013-12-01
Historia cen akcji firmy Holy Stone Healthcare Co., Ltd. od 2013 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) -0.29%
2025 -34.97%
2024 -38.74%
2023 -35.18%
2022 1.68%
2021 0.68%
2020 168.94%
2019 -26.05%
2018 -12.91%
2017 -1.95%
2016 -46.23%
2015 -26.48%
2014 -52.19%
2013 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$61.63 67.11%
US
$52.00 75.53%
SE
$195.83 45.38%
FR
$119.62 69.92%
US
$62.93 2.96%
IT